Susquehanna International Group, LLP Clearside Biomedical, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	SELL	$1.2 - $2.02 $26,520 - $44,642	-22,100 Reduced 60.88%	14,200 $21,000
Q4 2023 Feb 14, 2024	SELL	$0.68 - $1.18 $680 - $1,180	-1,000 Reduced 2.68%	36,300 $42,000
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.27 $15,170 - $23,495	-18,500 Reduced 33.15%	37,300 $32,000
Q2 2023 Aug 11, 2023	SELL	$0.97 - $1.48 $6,499 - $9,916	-6,700 Reduced 10.72%	55,800 $62,000
Q1 2023 May 16, 2023	BUY	$0.93 - $1.66 $38,688 - $69,056	41,600 Added 199.04%	62,500 $65,000
Q4 2022 Feb 14, 2023	SELL	$1.0 - $1.5 $3,000 - $4,500	-3,000 Reduced 12.55%	20,900 $23,000
Q3 2022 Nov 14, 2022	SELL	$1.08 - $1.83 $16,740 - $28,365	-15,500 Reduced 39.34%	23,900 $27,000
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.49 $12,480 - $23,904	-9,600 Reduced 19.59%	39,400 $58,000
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $130,815 - $279,072	-96,900 Reduced 66.42%	49,000 $112,000
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $410,992 - $864,292	-151,100 Reduced 50.88%	145,900 $401,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $356,937 - $532,080	73,900 Added 33.12%	297,000 $1.78 Million
Q2 2021 Aug 11, 2021	BUY	$2.32 - $5.38 $426,183 - $988,306	183,700 Added 466.24%	223,100 $1.09 Million
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $88,256 - $167,450	39,400 New	39,400 $97,000
Q1 2019 May 15, 2019	SELL	$1.1 - $1.74 $28,820 - $45,588	-26,200 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$1.0 - $6.12 $45,900 - $280,908	-45,900 Reduced 63.66%	26,200 $28,000
Q3 2018 Nov 14, 2018	BUY	$6.03 - $11.24 $116,982 - $218,056	19,400 Added 36.81%	72,100 $443,000
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $31,185 - $50,890	3,500 Added 7.11%	52,700 $563,000
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $274,044 - $702,576	49,200 New	49,200 $528,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

13.4M

Call Options Held

17.6K

Put Options Held

100

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account